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Abstract
Background
Current laboratory diagnosis of Buruli ulcer (BU) is based on microscopic detection of acid
fast bacilli, quantitative real-time PCR (qPCR), histopathology or cultivation. Insertion
sequence (IS) 2404 qPCR, the most sensitive method, is usually only available at reference
laboratories. The only currently available point-of-care test, microscopic detection of acid
fast bacilli (AFB), has limited sensitivity and specificity.
Methodology/ Principal Findings
Here we analyzed AFB positive tissue samples (n = 83) for the presence, distribution and
amount of AFB. AFB were nearly exclusively present in the subcutis with large extracellular
clusters being most frequently (67%) found in plaque lesions. In ulcerative lesions small
clusters and dispersed AFB were more common. Beside this, 151 swab samples from 37
BU patients were analyzed by IS2404 qPCR and ZN staining in parallel. The amount ofM.
ulcerans DNA in extracts from swabs correlated well with the probability of finding AFB in
direct smear microscopy, with 56.1% of the samples being positive in both methods and
43.9% being positive only in qPCR. By analyzing three swabs per patient instead of one,
the probability to have at least one positive swab increased from 80.2% to 97.1% for qPCR
and from 45% to 66.1% for AFB smear examination.
Conclusion / Significance
Our data show thatM. ulcerans bacteria are primarily located in the subcutis of BU lesions,
making the retrieval of the deep subcutis mandatory for examination of tissue samples for
AFB. When laboratory diagnosis is based on the recommended less invasive collection of
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swab samples, analysis of three swabs from different areas of ulcerative lesions instead of
one increases the sensitivity of both qPCR and of smear microscopy substantially.
Author Summary
Currently, four laboratory methods are available to diagnose Buruli ulcer, a neglected trop-
ical skin disease caused byMycobacterium ulcerans affecting mainly children in remote
rural areas of West Africa. Only one of the four methods, direct microscopic examination
of wound exudate for acid fast bacilli, is suitable as point-of-care test. The others, histopa-
thology, culture and IS2404 quantitative PCR, require sophisticated laboratory infrastruc-
ture. However, in comparison to the current gold standard, IS2404 quantitative PCR,
microscopic smear examination has limited sensitivity. Our results on the distribution of
M. ulcerans in Buruli ulcer lesions emphasize that the sensitivity of Buruli ulcer laboratory
diagnosis is dependent on optimal sampling procedures. Accurate histopathology crucially
depends on tissue samples containing all three skin layers, including the subcutis in which
the majority of the bacteria are found. For IS2404 quantitative PCR, culture and direct
smear detection, the margin of ulcerative lesions should be sampled at several positions,
since bacteria and bacterial DNA are unevenly distributed. With optimized sampling,
well-trained laboratory personnel and good microscopy infrastructure, direct smear exam-
ination reached a sensitivity of 73%, as compared to IS2404 quantitative PCR.
Introduction
Buruli ulcer (BU) is a devastating disease of the skin and subcutis, resulting from infection with
Mycobacterium ulcerans [1–3]. BU lesions present as non-ulcerative (papules, nodules, plaques
or oedema) or ulcerative forms. Extensive ulcerated wounds often lead to permanent disabili-
ties. Especially in remote rural areas of Africa diagnosis is often clinical and its accuracy
depends strongly on the experience of the local health staff [4]. The differential diagnosis of BU
includes diseases like cutaneous tuberculosis, cutaneous leishmaniasis and squamous cell carci-
noma [3]. Because of this and also because the current standard antibiotic treatment is associ-
ated with relevant side effects it is important to reconfirm the initial clinical diagnosis by a
laboratory test. The detection of theM. ulcerans specific insertion sequence 2404 (IS2404) in
tissue samples, swabs or fine needle aspirates (FNA) by quantitative real-time PCR (qPCR) is
the current gold standard to diagnose BU disease [3,4]. Other available diagnostic methods are
based on the ability to culture the bacteria, the presence of typical histopathological features in
skin biopsies or the direct detection of acid fast bacilli (AFB). Compared to qPCR, both micros-
copy and culture have limited sensitivity and may give false negative results [5]. This is in part
due to the uneven distribution of the bacteria in BU lesions. Already in 1948 Mac Callum
described the presence of “grouped masses of acid fast bacilli” inside BU lesions [6]. In 2006
Rondini et al. analyzed the horizontal distribution of AFB across entire lesions by correlating
histopathology with semi-quantitative IS2404 qPCR results [7]. AFB were found to be focally
clustered with some bacteria detectable in the peripheral, macroscopically healthy tissue [7].
For laboratory reconfirmation of clinically BU-suspicious ulcerative lesions it is recom-
mended to swab the wounds with sterile cotton swabs [4]. Swabs can be used for culture,
IS2404 qPCR analysis and for preparing smears for direct microscopic detection of AFB [4]. It
is recommended by the World Health Organization (WHO) to swab the undermined edges
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instead of the lesion core because it is assumed that the bacterial load is higher there. The pres-
ent study aimed at exploring the distribution and presence of AFB at the margin of ulcerative
BU lesions and in plaques by qPCR, smear microscopy and histopathology in a large BU
patient group.
Materials and Methods
Ethics statement
Ethical approval for analyzing patient specimens was obtained from the ethical review board of
the Ministry of Health of Benin (N° IRB00006860), the Cameroon National Ethics Comitee
(N°041/CNE/DNM/09,N°172/CNE/SE/2011 and ISRCTN72102977) and the Ghana Noguchi
Memorial Institute for Medical research (FWA00001824). Written informed consent from the
patients or their guardians was obtained before specimens were collected for reconfirmation of
BU as well as for detailed histopathological analysis and all patient data have been
anonymized.
Tissue samples
Punch biopsies were taken before, during or after treatment, both for the initial diagnosis and
subsequent monitoring of the response to treatment [8–11]. Excisions were only done for some
patients, based on the judgment of the responsible clinician [8].
Altogether 378 tissue samples from 219 laboratory reconfirmed (at least one IS2404 qPCR
positive swab) BU patients were histopathologically analyzed and AFB were found in 94
(24.9%) of these tissue samples coming from 72 patients. Eleven AFB positive skin samples had
to be excluded from the analysis because of incomplete recovery of skin layers. The remaining
83 tissue specimens coming from 63 patients were analyzed for the abundance and distribution
of AFB by histopathology. Lesions of 61/63 AFB positive patients were located at the extremi-
ties. 68/83 (81.9%) tissue samples came from ulcerative lesions and 15/83 (18.1%) from pla-
ques. From ulcerated BU lesions punch biopsies were taken at the outer margin of the lesion at
the border of the indurated to normal tissue, well beyond the undercutting to not miss the sub-
cutis. In contrast, from BU plaque lesions punch biopsies were collected from the non-ulcer-
ated center of the lesion.
Histopathological analysis
Tissue samples (4 mm punch biopsies or surgical excisions) were aseptically removed and
immediately fixed in 10% neutral-buffered formalin for 24 h to maintain tissue structures.
Afterwards they were transferred to 70% ethanol for storage and transport. Tissue specimens
were then dehydrated, embedded into paraffin, and cut into 5 μm thin formalin fixed paraffin
embedded (FFPE) tissue sections. After deparaffinization and rehydration, sections were
stained with Ziehl-Neelsen/Methylenblue (ZN, Sigma-Aldrich) according to WHO standard
protocols [4].
Tissue sections were analyzed with a Leica DM2500 Microscope. Pictures were either taken
with a Leica DFC 420C camera or with an Aperio ScanScope XT.
IS2404 quantitative PCR
Sterile dry cotton swabs were used to swab roughly equal sectors along the circumference of
the ulcers from 37 Cameroonian BU patients. From each patient 2–6 swabs (depending on the
lesion size), altogether 151 swabs, were collected by moving in a clockwise manner along the
borders of the lesions. Swabs were stored in the fridge until shipment to the Swiss TPH in
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Basel, Switzerland. DNA extraction of the whole swab and IS2404 qPCR was performed as
described by Lavender et al. [12]. CT values of samples taken at the same day from the same
lesion were compared with each other and the ΔCT value between the lowest and the highest
CT value was determined. Based on the ΔCT value, lesions were categorized into three different
groups: minimal heterogeneity (ΔCT 5), medium heterogeneity (5< ΔCT 10) and maxi-
mal heterogeneity (ΔCT> 10). The ΔCT value reflects the differences in DNA amount and
therefore the differences in bacterial load present at different positions of the lesions with a
ΔCT of 3.32 correlating to 10 times more target DNA. For the qPCR runs 1/50 of the DNA
extracted from the swabs was used.
Direct microscopic detection of AFB
Before storage of the swabs for qPCR analysis, part of the wound material on each swab was
applied onto a glass slide. Smears were fixed by pulling the glass slide three times through a
flame. Glass slides were stained with ZN [4] and embedded into Eukitt (Sigma-Aldrich)
mounting medium. Entire slides were analyzed for the presence of AFB with a Leica DM2500
microscope using the 40x and the 100x objectives.
Statistical analysis
The proportion of positive qPCR or smear microscopy tests when different numbers of swabs
are taken per patient was determined using a bootstrap with 1000 loops. 30 patients having had
at least 4 swabs (134 swabs in total) were selected for the calculations. First, one swab per
patient was chosen at random and the proportion of positive tests in the subsample was calcu-
lated. This was repeated 1000 times and the probability of obtaining one positive test when
only one swab is taken was computed by taking the mean of all proportions. A similar proce-
dure was followed to determine the probability of obtaining at least one or more positive tests
when two, three or four swabs are taken form a patient.
Results
Preferential localization ofM. ulcerans in the subcutis
In histopathological sections of BU lesions AFB presented either as i. single bacteria (Fig 1B1),
ii. small clusters of AFB (Fig 1B2) or iii. large clusters (Fig 2) located in a tissue depth of up to
10 mm in the FFPE sections (Fig 2). Since 10–30% shrinkage of the tissue is common in FFPE
tissue sections the true skin depth of theM. ulcerans bacteria was up to 1.3 cm (in excisions).
Similar numbers of tissue specimens could be assigned to each category: in 29/83 (35%) of the
microscopy AFB positive specimens only single bacteria were found, 28/83 (34%) samples con-
tained small clusters of AFB and 26/83 (31%) large clusters (Fig 1A). When specimens were
further stratified by lesion type, 67% (10/15) of the analyzed plaque specimens presented with
large clusters of extracellular bacteria, 13% (2/15) contained only small clusters and 20% (3/15)
displayed only single bacteria. In contrast, single bacteria (26/68; 38%) and small clusters (26/
68; 38%) dominated in the specimens originating from ulcers; here large clusters of AFB were
found in only 16/68 (24%) of the samples (Fig 1A).
AFB were not evenly distributed across the three main skin layers, epidermis, dermis and
subcutis. In none of the microscopy positive tissue samples AFB were detected in the epidermal
layer. Similarly the upper part of the dermis was never infected byM. ulcerans. However, single
cells or small clusters of AFB were occasionally found in the lower part of the dermis close to
the subcutis. In all tissue specimens comprising also the subcutis (n = 83) the majority of AFB
was found in this layer (Figs 1A and 2).
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Uneven distribution ofM. ulcerans DNA at the margins of ulcerative
lesions
We investigated the distribution of bacterial DNA and of AFB in ulcerative lesions of 37
untreated qPCR reconfirmed (at least one positive IS2404 qPCR positive swab; S1 and S2
Tables) BU patients by analyzing 151 swab samples taken from the lesion margins at different
positions of the same lesions (Fig 3 and S1 and S2 Figs). Altogether 18.5% (28/151) of the total
number of analyzed swabs were qPCR negative. The 28 qPCR negative swabs came from the
lesions of 15 patients (15/37, 40%). A total of 66 swabs from these 15 patients have been ana-
lyzed (S1 Table) and 42.4% (28/66) of these swabs had a negative qPCR result. However, each
of these 15 patients had at least one IS2404 qPCR positive swab. All 85 swabs taken from the
other 22 patients were IS240 qPCR positive. In comparative qPCR analyses of different swabs
taken from different areas of the same lesion, minimal heterogeneity (ΔCT 5) was found in
9/37 (24%), medium heterogeneity (5< ΔCT 10) in 17/37 (46%) and a maximal heterogene-
ity (ΔCT> 10) in 11/37 (30%) of the lesions (S1 and S2 Figs and S1 and S2 Tables), where a
ΔCT> 10 represents a more than 1000 fold difference in DNA quantity in different places of
one lesion.
The 151 swab samples, obtained from the 37 BU patients were also analyzed by microscopy
after direct ZN staining (Fig 4 and S1 and S2 Tables). All 28 PCR negative swabs were also
microscopy negative. Sixty-nine samples (56.1%) were positive in both tests and 54 samples
(43.9%) were only qPCR positive (Fig 4). AFB were microscopically detected in smears of all 51
swabs (41.5%) yielding a qPCR CT value of 27.8 (equaling about 300 genomes in the total
Fig 1. Preferential location ofM. ulcerans bacteria in the subcutis. A: In plaque lesions mainly large
clusters of extracellular bacteria were found, whereas in ulcerated lesions single AFB and small clusters were
more common. In both types of lesions AFB were primarily found in the subcutis. B: Examples for dispersed
single bacteria (1) and small clusters of AFB (2) in histological sections stained with ZN (counterstain
methylenblue).
doi:10.1371/journal.pntd.0004767.g001
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Fig 2. Localisation of large clusters of AFB in the subcutis of BU lesions. Histological sections were stained with
ZN (counterstain methylenblue). A: Cross sections through the excised tissue specimens from BU plaque lesions
(A2-A4, A7-A8) or ulcerated BU lesions (A1, A5-A6) revealing large clusters of AFB located in the subcutis in different
tissue depths (3 mm—10 mm). Boxed areas are shown in a higher magnification in (B). B: Large clusters of AFB. C:
High magnification of AFB with typical rod shaped appearance.
doi:10.1371/journal.pntd.0004767.g002
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extract of the swab [13]). In contrast, AFB were found in none of the 23 swabs (18.7%) yielding
a CT value 33.9 (equaling about 2 genomes in the total extract of the swab) [14]. Of the 49
swabs (39.8%) with a CT between 27.8 and CT 33.9, 18 (36.7%) were also positive in ZN smear
microscopy (Fig 4A), with a clear increase in the proportion of positive ZN smears with
decreasing qPCR CT value (Fig 4B). In total, 27/37 (73%) of the patients with at least one
qPCR positive swab had also at least one positive microscopy result.
Increase in test sensitivity by analyzing multiple swab samples
Results obtained with 134 swabs from those 30 patients who had at least four swabs taken from
different lesion areas were statistically analyzed for the effect of testing multiple samples on
assay sensitivity. Both for qPCR (Table 1) and for smear microscopy (Table 2) the probability
of obtaining at least one positive test result per patient increased substantially, when analyzing
two or three samples instead of one. In particular for qPCR the effect of analyzing a fourth
swab was only marginal.
Discussion
To date, no systematic analysis of the distribution ofM. ulcerans bacteria in BU lesions has
been published. Here we have systematically evaluated the amount and distribution of AFB in
83 tissue specimens in which we could detect AFB, corroborating previous findings that extra-
cellular clusters ofM. ulcerans bacteria in the subcutis are a histopathological hallmark of BU
[6–8,14,15]. In none of the 83 analyzed samples we found AFB in the epidermal layer, whereas
AFB were present in the subcutis of all complete tissue specimens with occasional minor spread
of bacteria into the lower layer of the dermis. As expected [8], large extracellular clusters of
AFB were found in most (67%) of the plaque lesions analyzed, but only in 24% of the ulcerated
lesions, where small clusters and dispersed AFB were more common. This is most likely related
to sloughing of necrotic tissue including the bulk of bacteria during ulcer formation [16,17].
Consequently, improper sampling of tissue specimens for histopathological analysis (e.g. not
including the subcutis) will often result in false negative laboratory results based on
Fig 3. Examples of lesions presenting with both IS2404 qPCR positive and negative swabs. Lesions of
six laboratory confirmed BU patients are shown, whereof four (# 1–4) presented with a ΔCT value 10,
indicating a minimal to medium heterogeneity and two (# 5 and 6) presented with a ΔCT value > 10, indicative
for a maximum heterogeneity. From each lesion four swabs have been taken in a clockwise manner and
IS2404 qPCR has been performed.
doi:10.1371/journal.pntd.0004767.g003
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microscopic detection of AFB in tissue specimens. Since no samples from nodular or edema-
tous lesions were available we are not able to draw any conclusions concerning these pre-ulcer-
ative forms.
Fine-needle aspiration (FNA) rather than taking punch biopsies is recommended [4] to
obtain samples from clinically-diagnosed non-ulcerative lesions (nodules, plaques and
Fig 4. Correlation between direct smear microscopy and IS2404 qPCR results.Of the 123 IS2404 qPCR
positive swab samples analyzed by direct smear microscopic analysis after ZN staining, 54 samples (43.9%) were
only positive by qPCR, whereas 69 samples (56.1%) were positive for both methods applied. Up to a qPCR CT of
27.8 all swabs were positive for both methods. Between CT 27.9 and CT 33.8 results were variable and above CT
33.8 all samples were microscopy negative. A: AFB positive and negative swabs in correlation to the qPCR values.
Each dot represents one swab sample. B: Percentage of AFB positive and negative swabs in correlation to qPCR
value ranges.
doi:10.1371/journal.pntd.0004767.g004
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oedema). However, FNA samples were not available for this study. Our findings on the distri-
bution of AFB may reflect a tropism ofM. ulcerans for the deeper subcutis, possibly related to
special nutritional needs only provided by the destroyed fat tissue. However, it cannot be
excluded that the location in the lower layers of the skin is rather the consequence of the inocu-
lation route, which is still unclear, but may either be via skin trauma or by insect bites. Skin tro-
pism is generally explained by the temperature preference ofM. ulcerans [4,18,19].
In ulcerative BU lesions disease activity is thought to be concentrated at the edges of ulcers
stretching into the indurated surroundings. Bacterial yield is expected to be highest below the
undermined edges, where laboratory specimen for direct smear microscopy, qPCR and cultiva-
tion should be obtained. However, it needs to be emphasized that the textbook like presenta-
tion with circularly undermined edges is the exception rather than the rule in most confirmed
BU lesions. In our patient cohort only a few patients had circular undermined edges, while all
the others presented with only partial or even no undercutting (S1 and S2 Tables). Here we
have addressed the question how evenly bacterial DNA is distributed in different areas of the
lesion by taking several swabs from the same lesion but from different areas. Samples were ana-
lyzed in parallel by IS2404 qPCR and direct smear microscopy for AFB. A high variability in
the distribution ofM. ulcerans DNA in different samples of the same lesions was observed and
from 40% of the lesions both IS2404 qPCR positive and negative swabs were obtained. This
supports the concept to repeat sampling if qPCR results are negative, but clinical signs and
symptoms are highly indicative for BU.
We observed a good correlation between the amount ofM. ulcerans DNA in extracts from
swabs and the positivity of direct smear microscopy. All swabs yielding extracts
containing 300M. ulcerans genomes had positive microscopy results, while swabs
yielding 2 genomes were all negative. About 35% of the swabs with DNA amounts between
Table 1. Increase in the probability of obtaining one or more positive qPCR results with the number of swabs analyzed.
Number of swabs
analyzed
Probability* of PCR positive tests (expressed as percentages)
% of one positive test
(95% CI)
% of two positive tests
(95% CI)
% of three positive test
(95% CI)
% of four positive test
(95% CI)
1 80.17 (79.81 to 80.52)
2 92.16 (91.96 to 92.41) 67.67 (67.37 to 67.98)
3 97.1 (96.25 to 97.24) 82.7 (82.47 to 82.95) 60.19 (59.95 to 60.43)
4 98.69 (98.57 to 98.80) 92.01 (91.90 to 92.10) 73.33 (73.28 to 73.38) 55.82 (55.67 to 55.97)
* A bootstrap with 1000 loops was used
doi:10.1371/journal.pntd.0004767.t001
Table 2. Increase in the probability of obtaining one or more positive smear microscopy results with the number of swabs analyzed.
Number of swabs
analyzed
Probability* of ZN smear positive tests (expressed as percentages)
% of one positive test
(95% CI)
% of two positive tests
(95% CI)
% of three positive test
(95% CI)
% of four positive test
(95% CI)
1 45.00 (44.63 to 45.38)
2 59.01 (58.70 to 59.32) 30.67 (30.33 to 30.93)
3 66.11 (65.87 to 66.35) 44.58 (44.37 to 44.79) 23.38 (23.14 to 23.61)
4 71.26 (71.11 to 71.41) 51.30 (51.20 to 51.40) 38.01 (37.91 to 38.11) 18.52 (18.38 to 18.67)
* A bootstrap with 1000 loops was used
doi:10.1371/journal.pntd.0004767.t002
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the above limits were microscopy positive. While the sensitivity of direct AFB detection in
smears was thus lower than that of IS2404 qPCR, 73% of all IS2404 qPCR positive patients
were also confirmed by microscopy by analyzing several swabs per patient. This value is high
compared to previous studies [20–22] and might not only be due to the number of swabs ana-
lyzed, but also to the covering of the slides with Eukitt mounting medium and a coverslip
immediately after staining, which protects the slides from attachment of dust and dirt and
good laboratory equipment. Our analyses also indicate that for qPCR analyzing three swab
samples may be an optimal number. However we have to emphasize that for this study each
swab was taken from a different area of the lesion and if the margin of the whole lesion is sam-
pled with one swab, results may be different. Overall, all diagnostic tests rely on a careful sam-
pling and in case of a negative result but a high clinical suspicion repeated testing may be
advisable.
Supporting Information
S1 Table. Patients from whom not all analyzed swabs were positive by IS2404 qPCR.
(DOCX)
S2 Table. Patients from whom all analyzed swabs were positive by IS2404 qPCR.
(DOCX)
S1 Fig. Lesions from which both IS2404 qPCR positive and negative swabs were obtained.
Depicted are all analyzed lesions that presented with both positive and negative IS2404 qPCR
results, sorted by the ΔCT heterogeneity. Picture numbers correspond to the patient numbers
in S1 Table.
(TIF)
S2 Fig. Lesions from which only positive IS2404 qPCR swabs were obtained. All analyzed
lesions that presented with positive IS2404 qPCR results, sorted by the ΔCT heterogeneity are
shown. Picture numbers correspond to the patient numbers in S2 Table.
(TIF)
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